# Rigel Pharmaceuticals Inc: Form 8-K, filed Feb 22, 2024

- Company: [Rigel Pharmaceuticals Inc](/companies/rigl.md) (CIK 1034842)
- Form: 8-K
- Filed: 2024-02-22
- Accepted by EDGAR: Feb 22, 2024, 08:00 ET
- Period: 2024-02-22
- Accession: 0001104659-24-026338
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1034842/000110465924026338/tm246898d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1034842/000110465924026338/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.01: Completion of an acquisition or disposition

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1034842/000110465924026338/tm246898d1_8k.htm

Filed Feb 22, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-026338. Last ingested by Listed: Nov 5, 2026, 17:27 ET. No prices; not investment advice.